PL2801352T3 - Orally disintegrating formulations of Lacosamid - Google Patents
Orally disintegrating formulations of LacosamidInfo
- Publication number
- PL2801352T3 PL2801352T3 PL14167375T PL14167375T PL2801352T3 PL 2801352 T3 PL2801352 T3 PL 2801352T3 PL 14167375 T PL14167375 T PL 14167375T PL 14167375 T PL14167375 T PL 14167375T PL 2801352 T3 PL2801352 T3 PL 2801352T3
- Authority
- PL
- Poland
- Prior art keywords
- lacosamid
- orally disintegrating
- disintegrating formulations
- formulations
- orally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR201305490 | 2013-05-08 | ||
TR201305664 | 2013-05-13 | ||
EP14167375.6A EP2801352B1 (en) | 2013-05-08 | 2014-05-07 | Orally disintegrating formulations of Lacosamid |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2801352T3 true PL2801352T3 (en) | 2017-12-29 |
Family
ID=50630711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL14167375T PL2801352T3 (en) | 2013-05-08 | 2014-05-07 | Orally disintegrating formulations of Lacosamid |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2801352B1 (en) |
ES (1) | ES2643287T3 (en) |
PL (1) | PL2801352T3 (en) |
WO (1) | WO2014180920A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112018012870A2 (en) | 2015-12-30 | 2018-12-04 | Adamas Pharmaceuticals Inc | methods and compositions for the treatment of crisis-related disorders |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090298947A1 (en) * | 2008-05-28 | 2009-12-03 | Pliva Hrvatska D.O.O. | Polymorphic and amorphous forms of lacosamide and amorphous compositions |
DE102008059155A1 (en) * | 2008-11-27 | 2010-06-02 | Ratiopharm Gmbh | Dry processing and new forms of lacosamide |
MX350056B (en) * | 2009-11-03 | 2017-08-25 | Lupin Ltd | Modified release formulation of lacosamide. |
WO2011130615A2 (en) * | 2010-04-15 | 2011-10-20 | Dr. Reddy's Laboratories Ltd. | Preparation of lacosamide |
EP2468261A1 (en) * | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulation of lacosamide |
-
2014
- 2014-05-07 ES ES14167375.6T patent/ES2643287T3/en active Active
- 2014-05-07 EP EP14167375.6A patent/EP2801352B1/en active Active
- 2014-05-07 PL PL14167375T patent/PL2801352T3/en unknown
- 2014-05-07 WO PCT/EP2014/059375 patent/WO2014180920A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2014180920A1 (en) | 2014-11-13 |
EP2801352B1 (en) | 2017-07-05 |
EP2801352A1 (en) | 2014-11-12 |
ES2643287T3 (en) | 2017-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20190173T1 (en) | Oral formulations of deferasirox | |
HK1212701A1 (en) | Formulations of enzalutamide | |
EP3065716C0 (en) | Formulations | |
HK1221416A1 (en) | Formulations of oxabicycloheptanes and oxabicycloheptenes | |
IL245855A0 (en) | Oral formulations of pyrrolydine derivatives | |
GB201319792D0 (en) | Formulations | |
HK1201841A1 (en) | Stable solid forms of regadenoson | |
HK1224228A1 (en) | Novel formulations | |
HK1214951A1 (en) | Ophthalimic formulations | |
HK1220139A1 (en) | Orally disintegrating tablet | |
GB2516028B8 (en) | Improved structure of shoe | |
PL2801352T3 (en) | Orally disintegrating formulations of Lacosamid | |
PL3071575T3 (en) | Preparation of normorphinans | |
PL2848260T3 (en) | Novel formulations of thiocolchicoside | |
TWM475821U (en) | Structure of mosquito-catch | |
TWM475524U (en) | Structure of rivet-pulling | |
GB201304608D0 (en) | BenTime of Yisrael operable arrangement |